Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Self-reported versus GPS-derived indicators of daily mobility in a sample of healthy older adults.

Fillekes MP, Röcke C, Katana M, Weibel R.

Soc Sci Med. 2018 Nov 9;220:193-202. doi: 10.1016/j.socscimed.2018.11.010. [Epub ahead of print]

2.

Virtual Reality Experiments with Physiological Measures.

Weibel RP, Grübel J, Zhao H, Thrash T, Meloni D, Hölscher C, Schinazi VR.

J Vis Exp. 2018 Aug 29;(138). doi: 10.3791/58318.

PMID:
30222166
3.

A Networked Desktop Virtual Reality Setup for Decision Science and Navigation Experiments with Multiple Participants.

Zhao H, Thrash T, Wehrli S, Hölscher C, Kapadia M, Grübel J, Weibel RP, Schinazi VR.

J Vis Exp. 2018 Aug 26;(138). doi: 10.3791/58155.

PMID:
30199016
4.

Environmental factors drive language density more in food-producing than in hunter-gatherer populations.

Derungs C, Köhl M, Weibel R, Bickel B.

Proc Biol Sci. 2018 Aug 22;285(1885). pii: 20172851. doi: 10.1098/rspb.2017.2851.

PMID:
30135170
5.

Home ranges of lions in the Kalahari, Botswana exhibit vast sizes and high temporal variability.

Zehnder A, Henley S, Weibel R.

Zoology (Jena). 2018 Jun;128:46-54. doi: 10.1016/j.zool.2018.04.001. Epub 2018 Apr 9.

PMID:
29735343
6.

Developing and Integrating Advanced Movement Features Improves Automated Classification of Ciliate Species.

Soleymani A, Pennekamp F, Petchey OL, Weibel R.

PLoS One. 2015 Dec 17;10(12):e0145345. doi: 10.1371/journal.pone.0145345. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0148592.

7.

Analysis and visualisation of movement: an interdisciplinary review.

Demšar U, Buchin K, Cagnacci F, Safi K, Speckmann B, Van de Weghe N, Weiskopf D, Weibel R.

Mov Ecol. 2015 Mar 10;3(1):5. doi: 10.1186/s40462-015-0032-y. eCollection 2015. Review.

8.

Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.

Weibel R, Reiss D, Karchewski L, Gardon O, Matifas A, Filliol D, Becker JA, Wood JN, Kieffer BL, Gaveriaux-Ruff C.

PLoS One. 2013 Sep 12;8(9):e74706. doi: 10.1371/journal.pone.0074706. eCollection 2013.

9.

Neuropathology of vaccination in infants and children.

Rorke-Adams LB, Evans G, Weibel RE, Johann-Liang R.

Vaccine. 2011 Nov 3;29(47):8754-9. doi: 10.1016/j.vaccine.2011.07.122. Epub 2011 Aug 18.

PMID:
21854821
10.

Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.

Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, Maldonado R, Kieffer BL.

Pain. 2011 Jun;152(6):1238-48. doi: 10.1016/j.pain.2010.12.031. Epub 2011 Feb 3.

PMID:
21295407
12.

Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program.

Weibel RE, Benor DE.

Arthritis Rheum. 1996 Sep;39(9):1529-34. Erratum in: Arthritis Rheum 1996 Nov;39(11):1930.

PMID:
8814065
14.

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.

Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL.

Arch Pediatr Adolesc Med. 1994 May;148(5):479-85.

PMID:
8180638
15.

[Febrile status in a traveler returning from the tropics with right-sided upper abdominal pain].

Weibel R.

Schweiz Rundsch Med Prax. 1993 Feb 2;82(5):144-8. German.

PMID:
8434207
16.

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.

Kuter BJ, Weibel RE, Guess HA, Matthews H, Morton DH, Neff BJ, Provost PJ, Watson BA, Starr SE, Plotkin SA.

Vaccine. 1991 Sep;9(9):643-7.

PMID:
1659052
17.

[An unusual case of imported malaria].

Weibel R, Stürchler D, Pirovino M.

Schweiz Rundsch Med Prax. 1991 May 28;80(22):613-4. German.

PMID:
2052829
18.

Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge.

Plotkin SA, Starr SE, Friedman HM, Gönczöl E, Weibel RE.

J Infect Dis. 1989 May;159(5):860-5.

PMID:
2540247
19.

Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment.

Weibel RE, Kuter BJ, Neff BJ, Rothenberger CA, Fitzgerald AJ, Connor KA, Morton D, McLean AA, Scolnick EM.

JAMA. 1985 Nov 1;254(17):2435-9.

PMID:
2995697
20.

Resistance of seropositive volunteers to subcutaneous challenge with low-passage human cytomegalovirus.

Plotkin SA, Weibel RE, Alpert G, Starr SE, Friedman HM, Preblud SR, Hoxie J.

J Infect Dis. 1985 Apr;151(4):737-9. No abstract available.

PMID:
2982973
21.

Evacuating immobile patients using stairwell slides.

Brisebois G, Emmons S, Weibel R.

Dimens Health Serv. 1984 Dec;61(12):16, 39. No abstract available.

PMID:
6241163
22.

Live attenuated varicella virus vaccine. Efficacy trial in healthy children.

Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Buynak EB, et al.

N Engl J Med. 1984 May 31;310(22):1409-15.

PMID:
6325909
23.

Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture.

McAleer WJ, Markus HZ, Wampler DE, Buynak EB, Miller WJ, Weibel RE, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1984 Mar;175(3):314-9.

PMID:
6320212
24.

Live attenuated varicella vaccine: the KMcC strain in healthy children.

Arbeter AM, Starr SE, Weibel RE, Neff BJ, Plotkin SA.

Pediatrics. 1983 Mar;71(3):307-12.

PMID:
6298698
25.

A novel single-dose delivery system for vaccines.

McAleer WJ, Markus HZ, Buynak EB, Weibel RE, Villarejos VM, McLean AA, Hilleman MR.

J Biol Stand. 1982 Oct;10(4):329-33. No abstract available.

PMID:
7153221
26.

Live attenuated varicella vaccine: immunization of healthy children with the OKA strain.

Arbeter AM, Starr SE, Weibel RE, Plotkin SA.

J Pediatr. 1982 Jun;100(6):886-93.

PMID:
6283051
27.

Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.

Hilleman MR, Carlson AJ Jr, McLean AA, Vella PP, Weibel RE, Woodhour AF.

Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S31-42. Review.

PMID:
7025159
28.

Clinical and laboratory studies of KMcC strain live attenuated varicella virus.

Neff BJ, Weibel RE, Villarejos VM, Buynak EB, McLean AA, Morton DH, Wolanski BS, Hilleman MR.

Proc Soc Exp Biol Med. 1981 Mar;166(3):339-47. No abstract available.

PMID:
6259644
29.

Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27/3 rubella virus.

Weibel RE, Carlson AJ Jr, Villarejos VM, Buynak EB, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1980 Nov;165(2):323-6. No abstract available.

PMID:
7443721
30.

Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines.

Weibel RE, Buynak EB, McLean AA, Roehm RR, Hilleman MR.

Proc Soc Exp Biol Med. 1980 Nov;165(2):260-3. No abstract available.

PMID:
7443713
31.

Clinical and laboratory studies of live attenuated RA 27/3 and HPV 77-DE rubella virus vaccines.

Weibel RE, Villarejos VM, Klein EB, Buynak EB, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1980 Oct;165(1):44-9. No abstract available.

PMID:
6999498
32.

Persistence of Pneumococcal antibodies in human subjects following vaccination.

Vella PP, McLean AA, Woodhour AF, Weibel RE, Hilleman MR.

Proc Soc Exp Biol Med. 1980 Sep;164(4):435-8. No abstract available.

PMID:
7413663
33.

Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines.

Weibel RE, Buynak EB, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1979 Nov;162(2):328-32. No abstract available.

PMID:
515009
34.

Pneumococcal vaccines.

Hilleman MR, McLean AA, Vella PP, Weibel RE, Woodhour AF.

Pathol Biol (Paris). 1979 Nov;27(9):579-88. No abstract available.

PMID:
44742
35.

Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine.

Carlson AJ, Davidson WL, McLean AA, Vella PP, Weibel RE, Woodhour AF, Hilleman MR.

Proc Soc Exp Biol Med. 1979 Sep;161(4):558-63. No abstract available.

PMID:
39297
36.

Further investigations of live respiratory syncytial virus vaccine administered parenterally.

Buynak EB, Weibel RE, Carlson AJ, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1979 Feb;160(2):272-7. No abstract available.

PMID:
419156
37.

Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169.

Neff BJ, Weibel RE, Buynak EB, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1979 Jan;160(1):32-7. No abstract available.

PMID:
217022
38.

What you should know about new and current viral vaccines.

Weibel RE.

Mod Med Asia. 1978 Jun;14(6):28-34. No abstract available.

PMID:
207966
39.

Live respiratory syncytial virus vaccine administered parenterally.

Buynak EB, Weibel RE, McLean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1978 Apr;157(4):636-42. No abstract available.

PMID:
652803
40.
41.

Polyvalent pneumococcal polysaccharide vaccines.

Hilleman MR, McLean AA, Vella PP, Weibel RE, Woodhour AF.

Bull World Health Organ. 1978;56(3):371-5.

42.

Studies in human subjects of polyvalent pneumococcal vaccines (39894).

Weibel RE, Vella PP, McLean AA, Woodhour AF, Davidson WL, Hilleman MR.

Proc Soc Exp Biol Med. 1977 Oct;156(1):144-50. No abstract available.

PMID:
20642
43.

Adaptation of the growing lung to increased oxygen consumption. II. Morphometric analysis.

Hugonnaud C, Gehr P, Weibel R, Burri PH.

Respir Physiol. 1977 Feb;29(1):1-10.

PMID:
557828
44.

Long-term persistence of antibody following Enders' original and More attenuated live measles virus vaccine.

Buynak EB, Weibel RE, Mclean AA, Hilleman MK.

Proc Soc Exp Biol Med. 1976 Dec;153(3):441-3. No abstract available.

PMID:
1013156
45.

Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.

Weibel RE, Villarejos VM, Vella PP, Woodhour AF, Mclean AA, Hilleman MR.

Proc Soc Exp Biol Med. 1976 Dec;153(3):436-40. No abstract available.

PMID:
827748
46.

Long-term follow-up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines.

Weibel RE, Buynak EB, McLean AA, Hilleman MR.

Pediatrics. 1975 Sep;56(3):380-7.

PMID:
1161394
47.

Practical aspects concerning combined live viral vaccines.

Hielleman MR, Weibel RE, Buynak EB, Villarejos VM.

Schweiz Rundsch Med Prax. 1975 Jan 28;64(4):98-108. No abstract available.

PMID:
1208349
48.

Measles, mumps and rubella virus vaccines prepared from virus produced by unit process.

McAleer WJ, Buynak EB, Weibel RE, Villarejos WM, Scattergood EM, Wasmuth EH, McLean AA, Hilleman MR.

J Biol Stand. 1975;3(4):381-4. No abstract available.

PMID:
1184596
49.

[Development and evolution of an antimeasles vaccine].

Weibel RE.

Bol Oficina Sanit Panam. 1974 Aug;77(2):135-40. Spanish. No abstract available.

PMID:
4277803
50.

Ten-year follow-up study for safety of adjuvant 65 influenza vaccine in man.

Weibel RE, McLean A, Woodhour AF, Friedman A, Hilleman MR.

Proc Soc Exp Biol Med. 1973 Sep;143(4):1053-6. No abstract available.

PMID:
4743681

Supplemental Content

Loading ...
Support Center